Executable cancer models: successes and challenges.

Area of Science:

• Computational biology
• Cancer research
• Systems biology

Background:

• Cancer treatment decisions require integrating complex, multi-modal data (genomics, histopathology, imaging, proteomics).
• Existing data integration strategies often lack meaningful prediction and experimental verification capabilities.
• A need exists for novel approaches to synthesize vast biological information for clinical application.

Purpose of the Study:

• To explain how executable computational models address the need for comprehensive data integration in cancer research.
• To demonstrate the potential of executable models for predicting effective cancer therapies and advancing personalized medicine.
• To highlight the role of executable models in understanding oncogenic signaling pathways and tumor regulation.

Main Methods:

• Explanation of executable computational models and their structure.
• Application of automated reasoning to executable models for mechanistic insights.
• Discussion of extending models to patient-specific 'avatars' for personalized treatment prediction.

Main Results:

• Executable models provide a framework for comprehensive data integration and experimental validation.
• These models facilitate the interpretation of biological and clinical data, aiding in understanding cancer mechanisms.
• Executable models coupled with automated reasoning enhance the understanding of oncogenic signaling pathways.

Conclusions:

• Executable computational models are crucial for integrating diverse cancer data, offering predictive and verifiable insights.
• Patient-specific computational models ('avatars') hold significant promise for advancing personalized cancer treatments and precision medicine.
• Overcoming challenges in executable model development requires robust cross-disciplinary collaboration.